Skip to main content
Medical information Clinical review pending

Infection Testing

Dengue Fever IgM Antibody Test

The Dengue Fever IgM Antibody Test helps diagnose recent dengue virus infections by detecting IgM antibodies in the blood. It is recommended for individuals with symptoms like high fever, severe headaches, joint pain, rash, nausea, or vomiting, especially after travel to dengue-prone areas.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (serum)
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 1,404

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Dengue Fever IgM Antibody Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected recent dengue infection
  • ✓Presence of symptoms like high fever, severe headache, joint/muscle pain, rash
  • ✓Recent travel to dengue-endemic areas
  • ✓Differentiation from other febrile illnesses
02

In plain language

What this test helps you understand

This test is used to detect recent dengue virus infection by identifying IgM antibodies produced by the immune system in response to the virus. It aids in the diagnosis of dengue fever, particularly in the early stages of illness.
The Dengue Fever IgM Antibody Test is a diagnostic tool used to identify recent infections caused by the dengue virus. Dengue fever is a viral illness transmitted by mosquitoes, often causing flu-like symptoms and potentially serious complications. Early diagnosis is important for proper management.

This test measures the level of IgM antibodies in your blood. Your immune system produces these antibodies when fighting the dengue virus. The presence of IgM antibodies typically indicates a recent infection, usually within the past few weeks.

This test is recommended for individuals experiencing symptoms suggestive of dengue fever, such as high fever, severe headaches, muscle and joint pain, rash, nausea, or vomiting. It is also advisable for those who have recently traveled to regions where dengue fever is common.

Getting tested allows for timely medical care, helps distinguish dengue from other illnesses with similar symptoms, and guides treatment to prevent complications. Discuss your results with your doctor for accurate interpretation and further steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Confirm with the laboratory before booking.
SampleBlood sample (serum)
MethodologyImmunoassay (e.g., ELISA or rapid diagnostic test) for the detection of Dengue IgM antibodies.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects IgM antibodies, which typically appear a few days after symptom onset and may persist for several weeks. Results may be negative early in the infection or if the infection occurred longer than a few weeks ago. A negative result does not completely rule out dengue infection. Consult with a healthcare professional for interpretation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A positive result indicates the presence of IgM antibodies, suggesting a recent dengue virus infection. Discuss the result with your doctor.
A negative result may mean you do not have a recent dengue infection, or the infection occurred too early or too long ago for IgM antibodies to be detected. Consult your doctor.
IgM antibodies usually become detectable a few days after symptoms begin. Consult your doctor about the best time to test.
The test requires a blood sample, which involves a small needle prick. This is generally quick and causes minimal discomfort.
Fasting is generally not required for this test. However, confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp